• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体在氨基核苷肾病大鼠急性肾小管间质损伤中的作用。

Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis.

作者信息

Nomura A, Morita Y, Maruyama S, Hotta N, Nadai M, Wang L, Hasegawa T, Matsuo S

机构信息

Third Department of Internal Medicine, Nagoya University School of Medicine, Japan.

出版信息

Am J Pathol. 1997 Aug;151(2):539-47.

PMID:9250166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1857997/
Abstract

The present work was designed to elucidate the in vivo role of complement in the proteinuria-associated tubulointerstitial injury. Rats were intravenously injected with puromycin aminonucleoside, and massive proteinuria was observed within 5 days. Prominent tubulointerstitial injury characterized by proximal tubular degeneration, tubular dilatation, and leukocyte infiltration were observed 7 days after injection. C3 and C5b-9 were observed in the luminal side of proximal tubular cells. Renal function, assessed by inulin and para-aminohippurate clearance, was significantly decreased. To-assess the role of complement in this model, rats were injected with either cobra venom factor or soluble recombinant human complement receptor type 1 starting at day 3. These manipulations significantly improved tubulointerstitial pathology and para-aminohippurate clearance without affecting the degree of proteinuria. Deposition of C3 and C5b-9 was not detected in the kidney of rats depleted of complement by cobra venom factor. In rats treated with soluble complement receptor, C3 was still detected in the tubules, but deposition of C5b-9 was not observed. Soluble complement receptor was detected at the site of C3 deposition and in the urine. These data strongly suggest that complement plays a pivotal role in proteinuria-associated tubulointerstitial injury and that systemic complement depletion or inhibition of complement in the tubular lumen may diminish the tubulointerstitial damage.

摘要

本研究旨在阐明补体在蛋白尿相关的肾小管间质损伤中的体内作用。给大鼠静脉注射嘌呤霉素氨基核苷,5天内观察到大量蛋白尿。注射7天后观察到以近端肾小管变性、肾小管扩张和白细胞浸润为特征的显著肾小管间质损伤。在近端肾小管细胞的管腔侧观察到C3和C5b-9。通过菊粉和对氨基马尿酸清除率评估的肾功能显著下降。为了评估补体在该模型中的作用,从第3天开始给大鼠注射眼镜蛇毒因子或可溶性重组人补体受体1型。这些操作显著改善了肾小管间质病理和对氨基马尿酸清除率,而不影响蛋白尿程度。在经眼镜蛇毒因子耗尽补体的大鼠肾脏中未检测到C3和C5b-9的沉积。在用可溶性补体受体治疗的大鼠中,肾小管中仍可检测到C3,但未观察到C5b-9的沉积。在C3沉积部位和尿液中检测到可溶性补体受体。这些数据强烈表明补体在蛋白尿相关的肾小管间质损伤中起关键作用,并且全身补体耗竭或肾小管腔中补体的抑制可能减轻肾小管间质损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7334/1857997/0dd82a61f58f/amjpathol00020-0227-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7334/1857997/aca05e03c290/amjpathol00020-0224-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7334/1857997/af2d2fa0f8ef/amjpathol00020-0225-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7334/1857997/0dd82a61f58f/amjpathol00020-0227-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7334/1857997/aca05e03c290/amjpathol00020-0224-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7334/1857997/af2d2fa0f8ef/amjpathol00020-0225-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7334/1857997/0dd82a61f58f/amjpathol00020-0227-a.jpg

相似文献

1
Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis.补体在氨基核苷肾病大鼠急性肾小管间质损伤中的作用。
Am J Pathol. 1997 Aug;151(2):539-47.
2
The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis.补体在大鼠系膜增生性肾小球肾炎肾小管间质病变发病机制中的作用。
J Am Soc Nephrol. 1997 Sep;8(9):1363-72. doi: 10.1681/ASN.V891363.
3
Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome.补体膜攻击复合物(C5b-9)介导实验性肾病综合征中的间质性疾病。
J Am Soc Nephrol. 1999 Nov;10(11):2323-31. doi: 10.1681/ASN.V10112323.
4
Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement.一种抑制补体膜抑制剂功能的单克隆抗体在大鼠中诱导的肾小管间质损伤
J Clin Invest. 1995 Nov;96(5):2348-56. doi: 10.1172/JCI118291.
5
Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.与慢性氨基核苷肾病相关的不可逆肾小管间质损伤。血管紧张素I转换酶抑制可改善病情。
Am J Pathol. 1990 Dec;137(6):1323-32.
6
C5b-9 does not mediate chronic tubulointerstitial disease in the absence of proteinuria.在无蛋白尿的情况下,C5b - 9并不介导慢性肾小管间质疾病。
Kidney Int. 2005 Feb;67(2):492-503. doi: 10.1111/j.1523-1755.2005.67106.x.
7
Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats.L/N型钙通道拮抗剂西尼地平对嘌呤霉素氨基核苷诱导的大鼠肾病的肾保护作用。
Arzneimittelforschung. 2009;59(2):79-85. doi: 10.1055/s-0031-1296368.
8
Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria.补体调节蛋白Crry可调节蛋白尿诱导的肾间质疾病。
Kidney Int. 1999 Dec;56(6):2096-106. doi: 10.1046/j.1523-1755.1999.00765.x.
9
Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis.嘌呤霉素氨基核苷肾病慢性模型中组织蛋白酶和金属蛋白酶的活性受到抑制。
Kidney Blood Press Res. 1999;22(3):121-7. doi: 10.1159/000025917.
10
Transfer of tubulointerstitial nephritis in the Brown Norway rat with anti-tubular basement membrane antibody: quantitation and kinetics of binding and effect of decomplementation.用抗肾小管基底膜抗体在棕色挪威大鼠中转移肾小管间质性肾炎:结合的定量与动力学及补体灭活的影响
J Immunol. 1985 Dec;135(6):3911-7.

引用本文的文献

1
Back-table intra-arterial administration of C1 esterase inhibitor to deceased donor kidney allografts improves posttransplant allograft function: Results of a randomized double-blind placebo-controlled clinical trial.对死亡供体肾移植进行手术台上动脉内给予C1酯酶抑制剂可改善移植后移植物功能:一项随机双盲安慰剂对照临床试验的结果
Am J Transplant. 2025 Sep;25(9):1926-1939. doi: 10.1016/j.ajt.2025.05.003. Epub 2025 May 9.
2
Crosstalk between glomeruli and tubules.肾小球与肾小管之间的相互作用。
Nat Rev Nephrol. 2025 Mar;21(3):189-199. doi: 10.1038/s41581-024-00907-0. Epub 2024 Dec 6.
3
Apical tubular complement activation and the loss of kidney function in proteinuric kidney diseases.

本文引用的文献

1
Expression of complement in the brain: role in health and disease.补体在大脑中的表达:在健康与疾病中的作用。
Immunol Today. 1996 Oct;17(10):461-6. doi: 10.1016/0167-5699(96)20028-f.
2
Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: evidence for a role for insulin-like growth factor I.大量蛋白尿时肾小球超滤液的生物活性可能导致肾小管间质损伤:胰岛素样生长因子I作用的证据
J Clin Invest. 1996 Jul 1;98(1):116-24. doi: 10.1172/JCI118755.
3
Expression and function of monocyte chemoattractant protein-1 in experimental nephrotic syndrome.
顶端肾小管补体激活与蛋白尿性肾脏疾病中的肾功能丧失
Clin Kidney J. 2024 Jul 10;17(8):sfae215. doi: 10.1093/ckj/sfae215. eCollection 2024 Aug.
4
Filtration and tubular handling of EWE-hC3Nb1, a complement inhibitor nanobody, in wild type mice and a mouse model of proteinuric kidney disease.野生型小鼠和蛋白尿性肾病小鼠模型中补体抑制剂纳米抗体EWE-hC3Nb1的滤过及肾小管处理情况
FEBS Open Bio. 2024 Feb;14(2):322-330. doi: 10.1002/2211-5463.13752. Epub 2024 Jan 4.
5
IgA-dominant infection-related glomerulonephritis with NAPlr-positive tubulointerstitial nephritis.IgA 主导的感染相关性肾小球肾炎伴 NAPlr 阳性的肾小管间质性肾炎。
CEN Case Rep. 2023 Nov;12(4):402-407. doi: 10.1007/s13730-023-00782-x. Epub 2023 Mar 15.
6
Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes.尿补体蛋白与 2 型糖尿病患者肾脏疾病进展和死亡风险
Diabetes Care. 2018 Nov;41(11):2361-2369. doi: 10.2337/dc18-0699. Epub 2018 Aug 27.
7
Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.糖尿病肾病中的免疫与炎症:将机制转化为生物标志物和治疗靶点。
Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F716-F731. doi: 10.1152/ajprenal.00314.2016. Epub 2016 Aug 24.
8
Glomerular disease: Immunosuppressant-induced reduction of proteinuria in IgAN.肾小球疾病:免疫抑制剂诱导IgA肾病蛋白尿减少
Nat Rev Nephrol. 2016 Jun 17;12(7):380-2. doi: 10.1038/nrneph.2016.84.
9
C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuria.C5b-9在以选择性蛋白尿为特征的实验性急性肾小球疾病中不介导肾小管间质损伤。
World J Nephrol. 2016 May 6;5(3):288-99. doi: 10.5527/wjn.v5.i3.288.
10
The Expression Profile of Complement Components in Podocytes.足细胞中补体成分的表达谱
Int J Mol Sci. 2016 Mar 30;17(4):471. doi: 10.3390/ijms17040471.
单核细胞趋化蛋白-1在实验性肾病综合征中的表达及功能
Clin Immunol Immunopathol. 1996 Feb;78(2):140-51. doi: 10.1006/clin.1996.0023.
4
Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle.可溶性重组补体受体1阻断补体对骨骼肌缺血/再灌注损伤的微血管效应
J Immunol. 1993 Jun 1;150(11):5104-13.
5
The concentration-dependent disposition of intravenous p-aminohippurate in subjects with normal and impaired renal function.静脉注射对氨基马尿酸在肾功能正常和受损受试者体内的浓度依赖性处置。
Br J Clin Pharmacol. 1993 Jan;35(1):20-9.
6
Differential expression of complement C3 and C4 in the human kidney.补体C3和C4在人肾脏中的差异表达。
J Clin Invest. 1993 Sep;92(3):1451-8. doi: 10.1172/JCI116722.
7
Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin).肾小球肾炎中的肾小管间质疾病。骨桥蛋白(尿桥蛋白)的潜在作用。
Am J Pathol. 1994 May;144(5):915-26.
8
Alternative pathway activation of complement by cultured human proximal tubular epithelial cells.培养的人近端肾小管上皮细胞对补体的替代途径激活
Kidney Int. 1994 Feb;45(2):451-60. doi: 10.1038/ki.1994.59.
9
Tubular catabolism of albumin is associated with the release of an inflammatory lipid.白蛋白的肾小管分解代谢与一种炎性脂质的释放有关。
Kidney Int. 1994 Jun;45(6):1697-709. doi: 10.1038/ki.1994.222.
10
Human high density lipoproteins stimulate endothelin-1 release by cultured human renal proximal tubular cells.人高密度脂蛋白刺激培养的人肾近端小管细胞释放内皮素-1。
Kidney Int. 1994 Nov;46(5):1315-21. doi: 10.1038/ki.1994.400.